Myriad Genetics Inc. (MYGN) Tops Q3 EPS by 6c, Raises FY11 Guidance
Tweet Send to a Friend
Myriad Genetics Inc. (NASDAQ: MYGN) reported Q3 EPS of $0.31, $0.06 better than the analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
